Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/12222
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShih, Yu-Shan-
dc.contributor.authorTsai, Wan-Ting-
dc.contributor.authorTsai, Wan-Ting-
dc.contributor.authorGuo, Bei-Chia-
dc.contributor.authorCheng, Aristine-
dc.contributor.authorWang, Jann-Tay-
dc.date.accessioned2025-07-19T02:42:15Z-
dc.date.available2025-07-19T02:42:15Z-
dc.date.issued2025-02-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/12222-
dc.description.abstractNeutralizing anti-interferon (IFN)-α autoantibodies can lead to immune dysregulation, potentially resulting in critical coronavirus disease 2019 (COVID-19). We report a case presenting with severe COVID-19 who was subsequently diagnosed to have thymoma and neutralizing anti-IFN-α autoantibodies.en_US
dc.language.isoen_USen_US
dc.publisherElsevier Taiwan LLCen_US
dc.subjectAnti-IFN-α autoantibodiesen_US
dc.subjectType 1 interferonsen_US
dc.subjectThymomaen_US
dc.subjectCritical COVID-19en_US
dc.subjectViral infectionsen_US
dc.titleLife-threatening COVID-19 in a thymoma patient with anti-interferon-α autoantibodiesen_US
dc.typeArticleen_US
Appears in Collections:Vol 58 No 3 (2025)

Files in This Item:
File Description SizeFormat 
Life-threatening-COVID-19-in-a-thymoma-patien_2025_Journal-of-Microbiology--.pdf1.52 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.